BANK OF MONTREAL /CAN/ - ALDER BIOPHARMACEUTICALS INC ownership

ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 146 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.22 and the average weighting 0.4%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of ALDER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$343,000
+36.1%
18,132
-15.4%
0.00%
Q2 2019$252,000
+20.6%
21,428
+39.7%
0.00%
Q1 2019$209,000
+23.7%
15,339
-7.3%
0.00%
Q4 2018$169,000
-37.2%
16,546
+2.6%
0.00%
Q3 2018$269,000
+5.5%
16,123
-0.0%
0.00%
Q2 2018$255,000
+27.5%
16,131
+2.6%
0.00%
Q1 2018$200,000
-52.6%
15,717
-57.4%
0.00%
Q4 2017$422,000
+76.6%
36,881
+89.1%
0.00%
Q3 2017$239,000
+408.5%
19,505
+370.8%
0.00%
Q2 2017$47,000
-59.8%
4,143
-26.0%
0.00%
Q1 2017$117,000
+2825.0%
5,602
+3047.2%
0.00%
Q4 2016$4,000
-33.3%
1780.0%0.00%
Q3 2016$6,000
+50.0%
1780.0%0.00%
Q2 2016$4,000
-50.0%
178
-45.1%
0.00%
Q1 2016$8,000
+14.3%
324
+54.3%
0.00%
Q4 2015$7,0000.0%2100.0%0.00%
Q3 2015$7,0002100.00%
Other shareholders
ALDER BIOPHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 2,942,130$40,160,00010.45%
Foresite Capital Management II, LLC 1,586,220$21,652,0009.78%
DAFNA Capital Management LLC 571,013$7,794,0003.36%
Redmile Group, LLC 8,244,896$112,543,0003.29%
Lion Point Capital, LP 1,271,500$17,355,0001.57%
Palo Alto Investors LP 1,861,630$25,411,0001.06%
SAMLYN CAPITAL, LLC 3,185,983$43,488,0001.03%
Bellevue Group AG 1,286,748$17,564,0000.97%
BB BIOTECH AG 2,766,008$37,756,0000.95%
Rock Springs Capital Management LP 1,560,000$21,294,0000.82%
View complete list of ALDER BIOPHARMACEUTICALS INC shareholders